Jaclyn Ho

Jaclyn Ho is the Director of Platform Biology at Eikon Therapeutics since July 2021. Prior to this role, Jaclyn worked at Tenaya Therapeutics starting as a Scientist I and progressing to Scientist II. Jaclyn completed their PhD in Molecular and Cell Biology at UC Berkeley under the mentorship of Dr. Robert Tjian. Jaclyn's early research experiences include work at notable institutions such as the Whitehead Institute, where Jaclyn focused on pluripotency and differentiation, and the Koch Institute for Integrative Cancer Research investigating immunogenicity against lung cancer. Jaclyn's academic background includes a B.S. in Biology from Massachusetts Institute of Technology.